Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01665833
Other study ID # SYNTAX
Secondary ID
Status Completed
Phase N/A
First received August 13, 2012
Last updated August 13, 2012
Start date January 2003
Est. completion date December 2011

Study information

Verified date August 2012
Source North Texas Veterans Healthcare System
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

We hypothesize that Coronary Artery Disease (CAD) severity assessed by SYNTAX score is an independent predictor of recurrent or persistent angina following coronary revascularization. The SYNTAX score is a score that suggests the severity of coronary artery disease detected by coronary angiography. Coronary revascularization is a procedure that occurs in two ways, a percutaneous coronary intervention (PCI) and a coronary artery bypass graft (CABG) and is done when there is narrowing and blockage or hardening of the arteries (atherosclerosis) surrounding the heart. Narrowing and blockages reduce blood flow to parts of the heart causing chest pain (known as angina) and sometimes myocardial infarction.


Description:

PCI and CABG are two well-established revascularization approaches to treatment of chronic angina caused by coronary atherosclerosis. Nevertheless, 35-42% of patients report recurring or persisting anginal symptoms after coronary revascularization. This can be attributed to many structural and functional causes, prominent amongst which is pre-revascularization angina severity, unrevascularized coronary territory, progression of native or bypass graft atherosclerosis, restenosis (re-narrowing of the vessels) and accompanying adjunctive pharmacotherapy.

The SYNTAX score is an angiographic tool for grading the complexity of coronary disease. It is the sum of points assigned to coronary lesions within one of the 16 segments of the coronary tree. The segments are given a 1,2, or 5 based on the disease presence as defined by the American Heart Association classification. The SYNTAX score has been used to help predict the outcomes of patients undergoing PCI with 3-vessel involvement (e.g. a triple bypass or 3-stent placement PCI). Those patients with the highest scores had the highest risk of a poor outcome with PCI revascularization compared to CABG. Despite these observations, the impact of CAD severity on post-revascularization angina, using the SYNTAX has never been systematically addressed in the current era.


Recruitment information / eligibility

Status Completed
Enrollment 4000000
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Any VA patient who has had an PCI from January 1, 2003 and December 31, 2011 and in the database used in protocol 09-018 (VA-CAP Study).

- Any VA patient who has received or will receive a 1-year follow up.

Exclusion Criteria:

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
North Texas Veterans Healthcare System

References & Publications (1)

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Hazard Rate Primary and secondary endpoints 1 year follow ups No
See also
  Status Clinical Trial Phase
Completed NCT04097912 - Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Withdrawn NCT03134105 - A Wearable EducAtional Intervention to REduce Angina N/A
Completed NCT02832115 - Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention Phase 4
Completed NCT02265796 - Ranolazine Among Unrevascularized Chronic Stable Angina Patients Phase 2
Terminated NCT00221182 - Stem Cell Study for Patients With Heart Disease Phase 1/Phase 2
Completed NCT01721096 - XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
Recruiting NCT01214499 - Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina Phase 2
Terminated NCT01285297 - Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction N/A
Withdrawn NCT00774891 - Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography N/A
Completed NCT02707783 - Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina
Completed NCT02065102 - Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty N/A
Completed NCT00946725 - To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg Phase 1
Recruiting NCT02439541 - Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Phase 1/Phase 2
Completed NCT02341664 - Patient and Provider Assessment of Lipid Management Registry
Withdrawn NCT00657514 - Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease Phase 4
Recruiting NCT01361659 - Shockwave Treatment for Advanced Angina in Maastricht N/A
Recruiting NCT05786417 - LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions Phase 4
Withdrawn NCT02507050 - Ivabradine and Post-revascularisation Microcirculatory Dysfunction Phase 4
Active, not recruiting NCT02468960 - Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS) N/A
Completed NCT01086228 - XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan N/A